FDA Adverse Event Injury Summary report: N

DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM

MDR report key: 4131309 · Received October 1, 2014

Report

Report Number
1416980-2014-33981
Event Type
Injury
Date Received
October 1, 2014
Date of Event
September 6, 2014
Report Date
September 6, 2014
Manufacturer
BAXTER HEALTHCARE CORPORATION
Product Code
KDI
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IN
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4). ON AN UNREPORTED DATE, THE PERITONITIS WAS RESOLVED AND THE PATIENT WAS RECOVERED FROM THE EVENT (PREVIOUSLY UNKNOWN). SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE, A FOLLOW-UP WILL BE SUBMITTED.

Additional Manufacturer Narrative · 1

(B)(4). THE REPORTED PRODUCT IS AN UNKNOWN BAXTER MINICAP. THIS REPORT INVOLVES THE SAME PATIENT AS IN (B)(4). THE DEVICE WAS NOT RETURNED; THEREFORE, A DEVICE ANALYSIS COULD NOT BE COMPLETED. SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.

Description of Event or Problem · 1

IT WAS REPORTED THAT A PATIENT EXPERIENCED PERITONITIS COINCIDENT WITH PERITONEAL DIALYSIS (PD) THERAPY. THE CAUSE OF THE PERITONITIS WAS UNKNOWN. IT WAS UNKNOWN IF THE PATIENT WAS HOSPITALIZED FOR THE PERITONITIS EVENT. ON AN UNREPORTED DATE, THE PATIENT WAS TREATED WITH VANCOMYCIN INJECTION 2 GRAM ONCE INTRAPERITONEALLY (IP) (ADDITIONAL FREQUENCY AND DURATION NOT REPORTED), FORTUM 1 GRAM DAILY UP TO 14 DAYS IP, AND HEPARIN 2 MILLILITER PER EVERY EXCHANGE (DOSAGE, ROUTE, FREQUENCY, AND DURATION NOT REPORTED) FOR THE PERITONITIS EVENT. DIANEAL THERAPY WAS ONGOING. IT WAS NOT REPORTED IF THE PATIENT WAS RECOVERING OR WAS RECOVERED FROM THE PERITONITIS EVENT. ADDITIONAL INFORMATION WAS REQUESTED BUT IS NOT AVAILABLE. THIS IS REPORT 3 OF 3.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
611418 DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM KDI BAXTER HEALTHCARE CORPORATION

Patients

Seq Age Sex Outcome Treatment
1 62 YR Required Intervention DIANEAL 2.5% ULTRABAG PD2| TRANSFER SET, TITANIUM ADAPTER